elite finds glp 1 I'm stuck in the gray market for GLP-1s What we still don't know
Description
They may only make structure/function claims accompanied by a disclaimer stating these claims have not been evaluated by the FDA
Gustavo Monnerat Fully agree, Gustavo this data isn't surprising once you stop treating obesity as a 1-year intervention instead of a chronic disease
A-11008
If the provider determines you are not a candidate for GLP-1 therapy, no prescription will be issued - that determination belongs entirely to the clinician, not to Oak's platform
